Cereussan
Product Images NDC 73479-011

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cereussan (NDC 73479-011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanpharmacy Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cereussan Label Capsules (Spy Cereussan 10 Capsules Label En 110x28)

FDA Label Image

Cereussan Outer-package Capsules (Spy Cereussan 10 Capsules Packaging En 40x40x65)

Cereussan Outer-package Capsules (Spy Cereussan 10 Capsules Packaging En 40x40x65)
This is a drug label providing information on "CereusSAN" capsules from sanPharmacy Inc. The capsules contain Bacillus cereus 6X to relieve symptoms of liver disorders caused by dysbacteria, chronic gastritis, chronic respiratory or rheumatic inflammation, minor skin irritations, dermatitis, and eczema. The user is advised to take 1-2 capsules per week at least 1 hour before eating. The product is manufactured in the USA and should be kept out of reach of children, with caution in cases of overdose. If symptoms persist after 5 days, it is recommended to contact a licensed practitioner. The label also includes contact information for adverse events reporting.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.